[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Surgery Partners CS (SGRY)

Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
SGRY Q1 Deep Dive: Stable Margins and Physician Recruitment Offset Volume Headwinds

SGRY Q1 Deep Dive: Stable Margins and Physician Recruitment Offset Volume Headwinds

SGRY : 14.59 (+2.31%)
Surgery Partners: Q1 Earnings Snapshot

Surgery Partners: Q1 Earnings Snapshot

SGRY : 14.59 (+2.31%)
Surgery Partners’s (NASDAQ:SGRY) Q1 CY2026 Sales Beat Estimates

Surgery Partners’s (NASDAQ:SGRY) Q1 CY2026 Sales Beat Estimates

SGRY : 14.59 (+2.31%)
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance

BRENTWOOD, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today...

SGRY : 14.59 (+2.31%)
Surgery Partners Set to Show Whether Last Year's Hospital Troubles Were Temporary or Structural

Barchart Research What to Expect from SGRY Earnings SGRY Generated May 4, 2026 Current Price $14.20 EPS Estimate $$-0.17 Consensus Rating Moderate Buy Average Move 6.39% Surgery Partners Set to Show Whether...

SGRY : 14.59 (+2.31%)
Surgery Partners (SGRY) Reports Q1: Everything You Need To Know Ahead Of Earnings

Surgery Partners (SGRY) Reports Q1: Everything You Need To Know Ahead Of Earnings

SGRY : 14.59 (+2.31%)
1 Mooning Stock with Impressive Fundamentals and 2 We Ignore

1 Mooning Stock with Impressive Fundamentals and 2 We Ignore

PWP : 19.34 (-1.12%)
SGRY : 14.59 (+2.31%)
EEFT : 69.67 (-1.05%)
1 Cash-Producing Stock to Target This Week and 2 We Question

1 Cash-Producing Stock to Target This Week and 2 We Question

F : 12.17 (+4.11%)
EPAM : 106.97 (-2.44%)
SGRY : 14.59 (+2.31%)
3 Profitable Stocks We Find Risky

3 Profitable Stocks We Find Risky

RSI : 27.86 (-4.49%)
SGRY : 14.59 (+2.31%)
GATX : 199.55 (+2.26%)
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

RGEN : 125.76 (+0.12%)
BAX : 16.98 (+1.37%)
CRL : 181.73 (-1.97%)
NVST : 27.07 (+3.36%)
SGRY : 14.59 (+2.31%)

Barchart Exclusives

Time to Buy: This Cheap High-Yield Dividend Stock Is Trading Near Multi-Year Lows
Accenture's dividend yield is now over 3.6% thanks to the decline in its stock price. The stock's valuations have started to appear tempting at these levels, even though there are lingering concerns over AI being a risk to the company's business. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.